[LXRX] YoY Quarter Result on 31-Dec-2017 [#Q4]

Stock
[LXRX] Lexicon Pharmaceuticals, Inc.
Announcement Date
28-Feb-2018
Financial Year
2017
Quarter
31-Dec-2017 [#Q4]
Profit Trend
QoQ- 7.63%
YoY- 12.46%
Quarter Report
LXRX's Result
LXRX's Financial Summary
View:
Show?
Quarter Result
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
Revenue 199 8,727 17,071 33,047 23,037 127,280 21,482 -54.13%
PBT -5,495 -51,138 -16,781 -32,387 -32,419 86,750 -3,003 10.58%
Tax -174 335 -102 -4,009 37 1,612 -70 16.37%
NP -5,495 -51,138 -16,781 -28,378 -32,419 86,750 -2,933 11.01%
Tax Rate - - - - - -1.86% - -
Total Cost 5,694 59,865 33,852 61,425 55,456 40,530 24,415 -21.52%
Ratio Analysis
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
NP Margin -2,761.31 -585.97 -98.30 -85.87 -140.73 68.16 -13.65 142.09%
Per Share
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
EPS -0.04 -0.48 -0.16 -0.27 -0.31 0.84 -0.03 4.90%
EPS Diluted -0.04 -0.48 -0.16 -0.27 -0.31 0.76 -0.03 4.90%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.